Skip to main content

Find Clinical Trials

Home
Conditions
Secondary Malignancies of T-cell Origin

Clinical trial condition

Secondary Malignancies of T-cell Origin

Explore clinical trials studying Secondary Malignancies of T-cell Origin. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Secondary Malignancies of T-cell Origin trial results

Recruiting

A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therapy

NCT07378969

Conditions: Secondary Malignancies of T-cell Origin
Locations: Novartis Investigative Site Kurume, Fukuoka, Japan

Novartis Investigative Site Osaka, Japan

Novartis Investigative Site Suita, Osaka, Japan

Novartis Investigative Site Bunkyo Ku, Tokyo, Japan

View Trial Details